Skip to main content
. 2018 Dec 27;16(4):1559325818803428. doi: 10.1177/1559325818803428

Figure 3.

Figure 3.

The time course of peer-reviewed studies of lycopene also begins in ∼1990 and growing rapidly since. Approximately 24% of that literature concerns cancer, and a very small minority (0.1%, we found just 5 studies, not discernible on this graph) concerns neuroprotection. Overall, the number of studies on lycopene is about one-third of the number available for resveratrol.